Role of circ_0012856 in modulating molecular pathways of diabetic peripheral neuropathy

Ji Chen1, Fan Zhang2, Yangyuxi Chen3

  • 1Department of Endocrinology Hunan University of Medicine General Hospital Huaihua Hunan China.

Insights

Diabetic peripheral neuropathy (DPN) involves complex pathways. Circ_0012856 was identified as a key regulator, offering potential therapeutic targets for DPN.

Area of Science:

  • Molecular biology
  • Genetics
  • Immunology

Background:

  • Diabetic peripheral neuropathy (DPN) is a common diabetes mellitus complication.
  • DPN pathogenesis involves intricate molecular pathways and the competing endogenous RNA (ceRNA) regulatory network.

Purpose of the Study:

  • To identify key circular RNAs (circRNAs) involved in DPN pathogenesis.
  • To elucidate the molecular mechanisms of identified circRNAs in DPN.
  • To explore potential therapeutic targets for DPN.

Main Methods:

  • Integration of diabetes-related circRNA datasets.
  • Application of least absolute shrinkage and selection operator (LASSO) and support vector machine recursive feature elimination (SVM-RFE) algorithms.
  • In vitro and in vivo experiments in cell and animal models.

Main Results:

  • Circ_0012856 was identified as a pivotal circRNA in DPN.
  • Circ_0012856 regulates EZH2 and STAT3 expression, inhibits autophagy, and promotes microglial M1 polarization.
  • Silencing circ_0012856 alleviated DPN symptoms in diabetic mice.
  • Circ_0012856 functions as a miR-124 sponge.

Conclusions:

  • Circ_0012856 plays a critical role in DPN progression.
  • Circ_0012856 influences key pathways, including inflammation and autophagy, in DPN.
  • Circ_0012856 represents a potential therapeutic target for DPN.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
412
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K